https://scholars.lib.ntu.edu.tw/handle/123456789/512227
標題: | Systemic steroids in acute exacerbation of COPD - From guidelines to bedside | 作者: | Wang P.-H. Cheng S.-L. HAO-CHIEN WANG Chang H.-T. Hsu Y.-L. Chen Y.-S. Chang C.-Y. |
公開日期: | 2011 | 卷: | 49 | 期: | 11 | 起(迄)頁: | 705-708 | 來源出版物: | International Journal of Clinical Pharmacology and Therapeutics | 摘要: | The optimal steroid dosages in AECOPD are still under debate. Admission records of patients in our hospital from January to December 2008 due to a diagnosis of AECOPD were reviewed. More wheezing and tachypnea were noted in the patients with a maximal daily prednisolone dose more than 60 mg. The steroid dose was higher in AECOPD without pneumonia than those concurrent with pneumonia. Those who had concurrent pneumonia had a higher risk of nosocomial infections. The study reflects the heterogeneity of AECOPD and that steroid dosages were determined by the clinical evaluation of the severity of illness and bacterial infections. ?2011 Dustri-Verlag Dr. K. Feistle. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054791410&doi=10.5414%2fCP201588&partnerID=40&md5=2cb7f874ae67965803ceed2937009ff8 https://scholars.lib.ntu.edu.tw/handle/123456789/512227 |
ISSN: | 0946-1965 | DOI: | 10.5414/CP201588 | SDG/關鍵字: | antibiotic agent; corticosteroid; prednisolone; steroid; article; bacterial infection; chronic obstructive lung disease; clinical evaluation; comorbidity; controlled study; disease exacerbation; disease severity; hospital infection; human; infection risk; major clinical study; outcome assessment; pneumonia; point of care testing; practice guideline; risk assessment; systemic therapy; treatment duration; unspecified side effect; Acute Disease; Adrenal Cortex Hormones; Humans; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Retrospective Studies |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。